JIANGXI TIANXIN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 603235 for the last quarter is 541.09 M CNY, and it's 4.60% lower compared to the previous quarter. The net income of Q3 24 is 149.31 M CNY.